Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
09/07/202406:26Alliance NewsAlliance NewsCOMMODITIES MARKET: Oil down as US hurricane fears abate; gold lower
09/07/202406:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:EUenCore Energy Corp
09/07/202406:25PR Newswire (US)Available Today, Thinking at the Speed of Bias, Shares Skills to Address the Unconscious Bias from Culture Competence Visionary
09/07/202406:24Business WireThe Sanborn Map Company Inc. Announces Acquisition of the assets of VeriDaaS
09/07/202406:20Alliance NewsAlliance NewsSivota shares collapse as Israeli subsidiary files for bankruptcyLSE:SIVSivota Plc
09/07/202406:20GlobeNewswire Inc.Aya Gold & Silver Pours First Silver at Expanded Zgounder MineTSX:AYAAya Gold & Silver Inc
09/07/202406:20PR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le mardi 9 juillet 2024/
09/07/202406:20GlobeNewswire Inc.NCI Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:NCINeo Concept International Group Holdings Ltd
09/07/202406:20PR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Tuesday, July 9, 2024/
09/07/202406:17GlobeNewswire Inc.Howard Hughes Holdings Inc. Announces Dates and Times for 2024 Second Quarter Earnings Release and Conference CallNYSE:HHHHoward Hughes Holdings Inc
09/07/202406:17GlobeNewswire Inc.Patagonia Gold Enters Into Option Agreement with Astra Exploration Inc. for Exploration and Development of La Manchuria Property in ArgentinaTSXV:PGDCPatagonia Gold Corp
09/07/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/07/202406:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
09/07/202406:15PR Newswire (US)TriMech Group Acquires Product Development Specialists MAKO Design + Invent to Expand Design and Engineering Services for Clients
09/07/202406:15PR Newswire (US)Strider & PayPal Support Growth in US $177B Equestrian Market
09/07/202406:15PR Newswire (US)BRENNAN AND ARCH STREET COMPLETE FIRST TRANSACTION IN LATEST JOINT VENTURE
09/07/202406:15PR Newswire (US)Mill Creek Announces Groundbreaking of Modera Chandler
09/07/202406:13GlobeNewswire Inc.Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results4565.T
09/07/202406:13GlobeNewswire Inc.Ascot Resources Announces C$20 Million Bought Deal FinancingTSX:AOTAscot Resources Ltd
09/07/202406:13Alliance NewsAlliance NewsCadence Minerals shares jump on upwardly revised Amapa project valueLSE:KDNCCadence Minerals Plc
09/07/202406:13PR Newswire (US)New EMA Research Indicates Enterprises are Ready to Leverage Network as a Service (NaaS) Solutions
09/07/202406:11Alliance NewsAlliance NewsIN THE KNOW: PageGroup to take short-term hit as plans for recoveryLSE:PAGEPagegroup Plc
09/07/202406:10GlobeNewswire Inc.Springbig Announces Strategic Partnership with Native Roots, Expanding Cannabis Loyalty Marketing ReachNASDAQ:SBIGWSpringBig Holdings Inc
09/07/202406:10GlobeNewswire Inc.Duolingo Doubles Down on Design and Animation With Acquisition of HobbesNASDAQ:DUOLDuolingo Inc
09/07/202406:08GlobeNewswire Inc.Symbeo partners with Amazon Business to extend the reach of its RapidInvoice AP automation solutionNASDAQ:CRVLCorVel Corp
09/07/202406:07Alliance NewsAlliance NewsIN BRIEF: Audioboom extends deal with five podcastsLSE:BOOMAudioboom Group Plc
09/07/202406:07Business WireAccess Vascular Appoints Medtech Veteran Heather Simonsen to Board of Directors
09/07/202406:07PR Newswire (US)37 Interactive Entertainment's Near term Targets Have Been Validated By SBTi
09/07/202406:05Business WireCI Financial Renews Normal Course Issuer Bid and Automatic Securities Purchase PlanAMEX:CIXCompX International Inc
09/07/202406:05GlobeNewswire Inc.uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s DiseaseNASDAQ:QUREuniQure NV